Effects of Supplement Containing Various Probiotics and Fermentation Products on Obesity
Launched by HIROSHIMA UNIVERSITY · Apr 13, 2009
Trial Information
Current as of May 29, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Healthy as based on medical history and physical examination
- • BMI between 25 and 30 kg/m2
- • Willing not to serve as blood donor during the study
- • Informed consent signed
- Exclusion Criteria:
- • Food allergy
- • Female subjects who are pregnant or nursing a child
- • Participation in any clinical trial up to 90 days before Day 01 of this study
- • Renal or hepatic dysfunction
- • Heart disease
- • Under medication
- • Subjects who are taking functional food designed for weight loss or serum lipid reduction
About Hiroshima University
Hiroshima University is a prestigious research institution in Japan, renowned for its commitment to advancing medical science and improving healthcare outcomes. With a strong focus on innovative clinical research, the university actively sponsors clinical trials aimed at developing novel therapies and enhancing patient care. Its multidisciplinary approach leverages expertise across various fields, fostering collaboration among researchers, clinicians, and industry partners. Through rigorous study design and adherence to ethical standards, Hiroshima University strives to contribute valuable insights to the global medical community while ensuring the highest level of participant safety and welfare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hiroshima, , Japan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials